Deutsch
A A A
Bereichsnavigation

Previous
RHÖN-KLINIKUM AG | 05/26/2020

German Federal Cartel Office approves planned acquisition of RHÖN-KLINIKUM AG by Asklepios Kliniken GmbH & Co. KGaA

RHÖN-KLINIKUM AG is advising that the German Federal Cartel Office has given its approval to the planned acquisition of up to 100 per cent of the interests in, and sole control over the Company by Asklepios Kliniken GmbH & Co. KGaA in the first review phase. This decision creates new legally valid majority relationships amongst the shareholders.

Stephan Holzinger, chairman of the Board of Management of RHÖN-KLINIKUM AG, said: “The decision by the Federal Cartel Office has created the basis for forging new paths at RHÖN-KLINIKUM AG with a new majority shareholder. RHÖN-KLINIKUM AG has an attractive portfolio of hospitals, medical excellence at the university level, innovative care models such as the campus approach, and numerous digitalisation projects that the Board of Management will continue to pursue steadfastly and with firm commitment. We continue to have an optimistic outlook for the future.”

For more information on the takeover offer, please refer to the published Statement at www.rhoen-klinikum-ag.com/takeover-offer.

 

Contact:

RHÖN-KLINIKUM AG | Head of Corporate Communications and Marketing
Elke Pfeifer
T. +49 9771 65-12110 | elke.pfeifer(at)rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Head of Investor Relations and Treasury
Julian Schmitt
T. +49 9771 65-12250 | julian.schmitt(at)rhoen-klinikum-ag.com